Autologus Esoxomes- Exomine TM
Exosomes in Aesthetic Medicine: Understanding the Science Behind Regenerative Skin Treatments
Regenerative aesthetics is moving beyond simply treating the visible signs of ageing. Modern approaches increasingly focus on supporting the biology of the skin, cellular communication and the body's own repair mechanisms. One of the most discussed developments in this field is the use of extracellular vesicles known as exosomes.
What Are Exosomes?
Exosomes are extremely small extracellular vesicles released by cells. They are part of a wider family known as extracellular vesicles (EVs) and are involved in communication between cells.
Rather than thinking of them simply as a substance that is "added" to the skin, it is more useful to understand exosomes as biological messengers. They can carry molecules including proteins, lipids and nucleic acids, which participate in cellular communication and signalling.
This ability to carry biological information is one of the reasons extracellular vesicles have attracted significant interest in regenerative medicine and aesthetic research.
Why Are Exosomes Interesting in Regenerative Aesthetics?
Traditional aesthetic medicine often focuses on correcting a visible concern: reducing the appearance of wrinkles, restoring volume or improving skin hydration. Regenerative aesthetics takes a different perspective.
The objective is to support the biological environment of the tissue and encourage healthier cellular activity rather than simply changing its appearance.
Cellular Communication
Exosomes participate in communication between cells and can transport biological signalling molecules.
Regenerative Research
Extracellular vesicles are being investigated for their potential role in tissue repair, regeneration and cellular signalling.
Personalised Medicine
Autologous approaches use biological material obtained from the patient's own body, creating a highly personalised treatment concept.
What Are Platelet-Derived Exosomes?
Not all exosomes are the same. Their biological characteristics can vary depending on the cells from which they originate.
Platelet-derived exosomes are extracellular vesicles associated with activated platelets. Platelets are already well known for their important role in the body's natural response to tissue injury and repair.
This makes platelet-derived extracellular vesicles particularly interesting in regenerative medicine, where researchers are investigating how their signalling properties may contribute to tissue repair and regeneration.
From correcting appearance to supporting biology
The appeal of regenerative aesthetics lies in its focus on tissue quality and biological processes rather than simply creating a temporary cosmetic effect.
What Is Exomine™?
Exomine™ is an autologous system designed to produce platelet-derived exosomes from the patient's own blood. According to the manufacturer's information, the process uses platelet-rich plasma together with a specialised microlyser system designed to encourage the release of extracellular vesicles from platelets.
The important word here is autologous. The biological material originates from the patient's own blood rather than from another person, animal or plant source.
This is fundamentally different from many commercially marketed "exosome" products, where the source and composition of the material may differ substantially.
How Does an Autologous Exosome Treatment Work?
The Exomine™ process begins with a blood sample. The collected blood is processed to prepare platelet-rich plasma, which is then subjected to the manufacturer's microlyser technology to facilitate the release of platelet-derived extracellular vesicles.
Blood Collection
A measured sample of the patient's own blood is collected under appropriate medical conditions.
PRP Preparation
The blood is processed to separate and concentrate the platelet-rich plasma.
Exosome Preparation
The platelet-rich fraction is processed using the Exomine™ microlyser system to release platelet-derived vesicles.
Mitrone's published information describes Exomine™ as producing a high concentration of platelet-derived vesicles, with approximately 20–25 billion exosomes stated for a typical 4–5 ml injectable treatment. These figures are manufacturer-provided specifications rather than a guarantee of clinical outcome.
Exosomes and PRP: Are They the Same?
No. Although the two approaches are closely related in an autologous regenerative treatment, they are not identical.
| PRP | Platelet-Derived Exosomes |
|---|---|
| Uses concentrated platelet-rich plasma from the patient's own blood. | Focuses on extracellular vesicles released by activated platelets. |
| Contains platelets, plasma proteins and a range of signalling molecules and growth factors. | Contains nanoscale vesicles involved in intercellular communication. |
| Has an established history of clinical use in a range of regenerative applications. | Represents a rapidly developing area of regenerative medicine research. |
In practice, PRP and exosome-based approaches should not automatically be considered interchangeable. The most appropriate option depends on the patient's condition, medical history, treatment objective and the evidence available for the intended use.
What Are Exosome Treatments Being Investigated For?
Extracellular vesicles are currently being investigated across a wide range of regenerative and biomedical applications. In aesthetic and dermatological contexts, interest includes skin quality, tissue repair, inflammation and hair biology.
- Skin quality and regenerative skin treatments
- Support of tissue repair and recovery
- Hair and scalp regenerative research
- Research into wound healing and tissue regeneration
- Cellular signalling and inflammatory pathways
It is important, however, to distinguish between scientific investigation and proven clinical indications. The existence of promising laboratory or early clinical research does not automatically mean that an exosome treatment is proven to treat a particular condition.
The Emerald Approach to Regenerative Aesthetics
At Emerald Aesthetic Clinic by Dr. Tünde, regenerative treatments are considered as part of a personalised medical strategy rather than as a trend or a one-size-fits-all procedure.
The starting point is always an individual consultation. Skin quality, facial anatomy, medical history, lifestyle, previous treatments and personal goals all matter when deciding whether a regenerative treatment is appropriate.
The aim is not to promise a dramatic overnight transformation. Instead, the Emerald philosophy is centred around subtle, natural-looking improvement and maintaining the individuality of every patient.
Why Medical Supervision Matters
Exosome-based treatments are part of a rapidly developing field. This is precisely why the source of the biological material, preparation method, sterility, product quality, intended route of administration and clinical evidence all matter.
Patients should be particularly cautious about products marketed online with broad claims about anti-ageing, hair growth or regeneration without clear information about their origin, manufacturing process and clinical evidence.
European regulators have also highlighted the importance of distinguishing regulated advanced therapies from unregulated products promoted directly to patients. The EMA advises patients to verify the regulatory status of advanced therapies and to discuss proposed treatments with qualified healthcare professionals. :contentReference[oaicite:1]{index=1}
In Ireland, medicinal products generally require appropriate authorisation by the HPRA or EMA, subject to specific legal pathways and exemptions. The regulatory position can depend on the exact product, preparation, intended use and route of administration. :contentReference[oaicite:2]{index=2}
Exosome Treatment: Frequently Asked Questions
No. Exosomes are extracellular vesicles released by cells. They are not living stem cells. Their role is primarily associated with intercellular communication and biological signalling.
Autologous means that the biological material is obtained from the same individual who receives the treatment. In an autologous Exomine™ approach, the starting material comes from the patient's own blood.
No. Suitability depends on the individual patient's medical history, current health, treatment goals and the specific protocol being considered. A medical consultation is essential before treatment.
Not necessarily. Exosome-based regenerative treatments have a different therapeutic concept. They are not designed simply to replace volume restoration with dermal fillers or muscle-relaxing treatments.
Research into extracellular vesicles is developing rapidly, but evidence varies according to the product, source, preparation method, route of administration and clinical indication. Patients should avoid interpreting early research as a guarantee of treatment results.
Curious Whether Regenerative Treatment Is Right for You?
The best treatment is not necessarily the newest treatment. At Emerald Aesthetic Clinic by Dr. Tünde, every recommendation begins with understanding you, your skin and your goals.
Book a Private ConsultationThis article is intended for general educational purposes and does not constitute individual medical advice, diagnosis or a treatment recommendation. Exosome and extracellular-vesicle technologies are an evolving area of regenerative medicine, and available evidence and regulatory requirements may change. Treatment suitability, safety, expected outcomes and regulatory status must be assessed for the individual patient and the specific product or protocol being considered.
